Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nurse- and peer-led psycho-educational intervention to support women with gynaecological cancers receiving curative radiotherapy: The PeNTAGOn randomised controlled trial - ANZGOG 1102.

Gynecologic oncology·2020
Same author

Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-reperfusion.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2020
Same author

Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival.

Blood cancer journal·2017
Same author

How rural and urban patients in Australia with colorectal or breast cancer experience choice of treatment provider: A qualitative study.

European journal of cancer care·2017
Same author

Relaxin-3 inputs target hippocampal interneurons and deletion of hilar relaxin-3 receptors in "floxed-RXFP3" mice impairs spatial memory.

Hippocampus·2017
Same author

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).

Leukemia·2016

Related Experiment Video

Updated: May 2, 2026

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
12:08

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Published on: November 15, 2024

1.1K

Development of human cells with RXFP1 knockdown using retroviral delivery of microRNA against human RXFP1.

K L Yong, G E Callander, R Bergin

    Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia
    |March 20, 2014
    PubMed
    Summary

    Researchers developed a microRNA to silence RXFP1 expression in human cells. This tool is valuable for studying relaxin receptor actions and developing new relaxin analogs.

    More Related Videos

    Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
    11:40

    Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

    Published on: October 20, 2014

    8.1K
    Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
    08:22

    Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

    Published on: May 31, 2020

    4.7K

    Related Experiment Videos

    Last Updated: May 2, 2026

    Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro
    12:08

    Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

    Published on: November 15, 2024

    1.1K
    Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
    11:40

    Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

    Published on: October 20, 2014

    8.1K
    Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
    08:22

    Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

    Published on: May 31, 2020

    4.7K

    Area of Science:

    • Cell biology
    • Molecular endocrinology
    • Receptor pharmacology

    Background:

    • Relaxin family peptides play crucial roles in various physiological processes.
    • Understanding relaxin's specific actions requires tools to modulate its cognate receptor, RXFP1.
    • Permanent knockdown of RXFP1 in human cells is essential for detailed mechanistic studies.

    Purpose of the Study:

    • To develop and validate a microRNA (miRNA) for stable knockdown of the human relaxin receptor RXFP1.
    • To assess the efficacy of the developed miRNA in reducing RXFP1 expression and function in human cells.
    • To establish a valuable tool for investigating relaxin signaling pathways and analog development.

    Main Methods:

    • Design and screening of four distinct microRNAs targeting human RXFP1.
    • Validation of RXFP1 knockdown by measuring relaxin binding in HEK-293T cells.
    • Retroviral delivery of the selected miRNA into human dermal fibroblast BJ3 cells.
    • Assessment of RXFP1 mRNA expression and functional consequences of knockdown on collagen deposition.

    Main Results:

    • One of the four designed microRNAs achieved significant RXFP1 knockdown.
    • The selected miRNA successfully reduced RXFP1 mRNA expression in BJ3 cells.
    • RXFP1 knockdown BJ3 cells lost the ability to respond to relaxin for reducing TGF-beta1-induced collagen deposition.

    Conclusions:

    • A retroviral miRNA-mediated system effectively silences RXFP1 expression in human dermal fibroblasts.
    • This established RXFP1 knockdown cell model is a powerful tool for studying relaxin receptor biology.
    • The developed miRNA is instrumental for investigating receptor specificity, signaling, and off-target effects of relaxin analogs.